We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cibus Inc | NASDAQ:CBUS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.155 | -5.54% | 2.645 | 1.01 | 3.60 | 3.0889 | 2.56 | 2.79 | 526,969 | 01:00:00 |
Webcast link: https://wsw.com/webcast/canaccord98/cbus/2460579
Webcast link: https://sidoti.zoom.us/webinar/register/WN_W6AVp9QSStSZC7B8Xih2Ww
About CibusCibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop traits to license to seed companies in exchange for royalties on seed sales. Cibus' focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. In total, Cibus has developed a pipeline of six productivity traits. It is commercializing its Pod Shatter Reduction trait in Canola and is a leader in weed management traits in Rice with its HT1 and HT3 traits with customers such as Loveland Products (Nutrien Ltd.) and Interoc S.A in the United States and Latin America. Its recent development of stacked herbicide tolerant traits in rice is an important milestone in developing better weed solutions in rice. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trial stages.
CIBUS CONTACTS:
INVESTOR RELATIONSKaren Troeberktroeber@cibus.com858-450-2636
Jeff Sonnek – ICRjeff.sonnek@icrinc.com
MEDIA RELATIONSmedia@cibus.com(619) 849-6009
Colin Sanfordcolin@bioscribe.com203-918-4347
1 Year Cibus Chart |
1 Month Cibus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions